These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 28893132

  • 21. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections.
    Wu YH, Chen PL, Hung YP, Ko WC.
    J Microbiol Immunol Infect; 2014 Jun; 47(3):197-203. PubMed ID: 23063776
    [Abstract] [Full Text] [Related]

  • 22. Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
    Veve MP, Wagner JL, Kenney RM, Grunwald JL, Davis SL.
    Int J Antimicrob Agents; 2016 Jul; 48(1):56-60. PubMed ID: 27234673
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
    Nakai H, Hagihara M, Kato H, Hirai J, Nishiyama N, Koizumi Y, Sakanashi D, Suematsu H, Yamagishi Y, Mikamo H.
    J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
    [Abstract] [Full Text] [Related]

  • 26. What are the risk factors for recurrent UTI with repeated ESBL-producing Enterobacteriaceae? A retrospective cohort study.
    Ahn ST, Lee HS, Han DE, Lee DH, Kim JW, Park MG, Park HS, Moon DG, Oh MM.
    J Infect Chemother; 2023 Jan; 29(1):72-77. PubMed ID: 36195248
    [Abstract] [Full Text] [Related]

  • 27. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital.
    Schoevaerdts D, Bogaerts P, Grimmelprez A, de Saint-Hubert M, Delaere B, Jamart J, Swine C, Glupczynski Y.
    BMC Infect Dis; 2011 Jan 12; 11():12. PubMed ID: 21226923
    [Abstract] [Full Text] [Related]

  • 28. [Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a Level III Hospital - A Retrospective Study].
    Simões A, Lima M, Brett A, Queiroz C, Chaves C, Oliveira H, Januário L, Rodrigues F.
    Acta Med Port; 2020 Jul 01; 33(7-8):466-474. PubMed ID: 31962058
    [Abstract] [Full Text] [Related]

  • 29. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K.
    Int Urol Nephrol; 2015 Jul 01; 47(7):1059-66. PubMed ID: 26026972
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC, Chen HH, Chen CL, Ou LS, Lin TY, Tsai MH, Chiu CH.
    J Microbiol Immunol Infect; 2014 Oct 01; 47(5):399-405. PubMed ID: 23834784
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Recent evolution of the epidemiological profile of extended-spectrum β-lactamase producing uropathogenic enterobacteria in Marrakech, Morocco].
    El Bouamri MC, Arsalane L, Kamouni Y, Berraha M, Zouhair S.
    Prog Urol; 2014 Jun 01; 24(7):451-5. PubMed ID: 24861685
    [Abstract] [Full Text] [Related]

  • 35. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.
    Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D.
    J Pediatr; 2013 Nov 01; 163(5):1417-21. PubMed ID: 23919903
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.